According to a study published in the New England Journal of Medicine on Monday, children who use the inhaled steroid, budesonide, to treat asthma can stunt growth by as much as half an inch.
An estimated 21.9 million Americans have asthma, according to the American College of Allergy, Asthma and Immunology (ACAAI). Symptoms can range from mild to life-threatening, and are a leading cause of work and school absences.
“Inhaled corticosteroids can be lifesaving for asthmatic children, although it is important to practice proper management,” said allergist Stanley Fineman, MD, president of the American College of Allergy, Asthma and Immunology. “A board-certified allergist can help parents understand the risks and benefits of treatment options.”
According to Dr. Fineman, the dose of inhaled steroids mentioned in the study dates back to the 1990s, and is double the dose that allergists prescribe today. It is imperative to consider all data on inhaled corticosteroids, since one study’s results will not change treatment guidelines.
Dr. Fineman is available to discuss what this study means for asthmatic children and the current treatment of asthma in the United States.
To arrange an interview, please contact Christine Westendorf – Media Relations Manager – American College of Allergy, Asthma and Immunology – 847.427.1200 – [email protected]
RSS